Cleveland BioLabs, Inc. (CBLI) Social Stream
Cytocom Inc (CBLI) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CBLI.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 1 | $40 | $40 | $40 | $3.42 | 1069.59% |
Price Target Last Issued April 8, 2014
CBLI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- CBLI has a higher number of analysts covering the stock than nearly none of all US stocks.
- The variance in analysts' estimates of CBLI is lower than almost 100% of all US stocks.
- Cytocom Inc's upside potential (average analyst target price relative to current price) is higher than 98.67% of all US stocks.
- The average analyst price target of CBLI is higher than 94.04% of stocks in the micro market cap category.
Is CBLI a Buy, Hold or Sell? See the POWR Ratings now!